Answers are grounded in this paper and cite their sources.
In routine practice with dosing individualized according to clinical condition, response, and tolerability, osilodrostat was effective and well tolerated regardless of CS etiology and severity.
No takes yet. Share an insight, caveat, or question.
Fleseriu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: